$1.54
0.000.00%
At close: -
$1.60
0.063.90%
After Hours: Jan 17, 7:26 PM EDT
Comments
Loading...
Iterum Therapeutics (NASDAQ:ITRM) Stock, Earnings Estimates, EPS, And Revenue
Iterum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 27
EPS Estimate
$-0.240
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Iterum Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Iterum Therapeutics (ITRM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.24 | $-0.21 | -14.3 % |
| Q2 | 2024-08-14 | $-0.23 | $-0.45 | 48.9 % |
| Q1 | 2024-05-13 | $-0.38 | $-0.72 | 47.2 % |
| Q4 | 2024-03-28 | $-0.81 | $-0.93 | 12.9 % |
Iterum Therapeutics (ITRM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?
Iterum Therapeutics (ITRM) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Iterum Therapeutics (NASDAQ:ITRM)?
The Actual EPS was $-0.24, which missed the estimate of $-0.21.
What were Iterum Therapeutics’s (NASDAQ:ITRM) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.